Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial
scientific article
Author/s
author: Robert Stuart, Parameswaran Hari, Hagop Kantarjian, Stefan Faderl, Farhad Ravandi, David Rizzieri, Karen Seiter, Gary J Schiller, Meir Wetzler, Tibor Kovacsovics, Eunice S Wang, Dirk Huebner
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.